Your browser doesn't support javascript.
loading
A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors.
Taubenschmid-Stowers, Jasmin; Orthofer, Michael; Laemmerer, Anna; Krauditsch, Christian; Rózsová, Marianna; Studer, Christian; Lötsch, Daniela; Gojo, Johannes; Gabler, Lisa; Dyczynski, Matheus; Efferth, Thomas; Hagelkruys, Astrid; Widhalm, Georg; Peyrl, Andreas; Spiegl-Kreinecker, Sabine; Hoepfner, Dominic; Bian, Shan; Berger, Walter; Knoblich, Juergen A; Elling, Ulrich; Horn, Moritz; Penninger, Josef M.
Afiliação
  • Taubenschmid-Stowers J; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna Biocenter, Vienna, Austria.
  • Orthofer M; JLP Health GmbH, Vienna, Austria.
  • Laemmerer A; Center for Cancer Research and Comprehensive Cancer Center-Central Nervous System Tumor Unit, Medical University of Vienna, Vienna, Austria.
  • Krauditsch C; Department of Pediatrics and Adolescent Medicine and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Rózsová M; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna Biocenter, Vienna, Austria.
  • Studer C; JLP Health GmbH, Vienna, Austria.
  • Lötsch D; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Gojo J; Center for Cancer Research and Comprehensive Cancer Center-Central Nervous System Tumor Unit, Medical University of Vienna, Vienna, Austria.
  • Gabler L; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
  • Dyczynski M; Department of Pediatrics and Adolescent Medicine and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Efferth T; Center for Cancer Research and Comprehensive Cancer Center-Central Nervous System Tumor Unit, Medical University of Vienna, Vienna, Austria.
  • Hagelkruys A; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
  • Widhalm G; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Peyrl A; JLP Health GmbH, Vienna, Austria.
  • Spiegl-Kreinecker S; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
  • Hoepfner D; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna Biocenter, Vienna, Austria.
  • Bian S; Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
  • Berger W; Department of Pediatrics and Adolescent Medicine and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Knoblich JA; Department of Neurosurgery, Kepler University Hospital GmbH, Johannes Kepler University Linz, Linz, Austria.
  • Elling U; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Horn M; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna Biocenter, Vienna, Austria.
  • Penninger JM; Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
EMBO Mol Med ; 15(3): e16959, 2023 03 08.
Article em En | MEDLINE | ID: mdl-36740985
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Artemisininas / Antimaláricos Limite: Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Artemisininas / Antimaláricos Limite: Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria